Total Payments
$952,789
2024 Payments
$48,802
Companies
20
Transactions
70
Medicare Patients
6,480
Medicare Billing
$4.8M
Payment Breakdown by Category
Research$526,350 (55.2%)
Consulting$272,361 (28.6%)
Royalty/License$114,070 (12.0%)
Travel$38,159 (4.0%)
Food & Beverage$1,848 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $526,350 | 3 | 55.2% |
| Consulting Fee | $272,361 | 5 | 28.6% |
| Royalty or License | $114,070 | 5 | 12.0% |
| Travel and Lodging | $38,159 | 6 | 4.0% |
| Food and Beverage | $1,848 | 51 | 0.2% |
Payments by Type
Research
$526,350
3 transactions
General
$426,439
67 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Catalyst Spinal Innovations | $526,350 | 3 | $0 (2019) |
| Spinevision SAS | $415,944 | 16 | $0 (2024) |
| Spinevision Inc. | $9,176 | 2 | $0 (2023) |
| GE HEALTHCARE | $280.31 | 17 | $0 (2024) |
| Celgene Corporation | $124.54 | 6 | $0 (2022) |
| ABBVIE INC. | $124.44 | 4 | $0 (2024) |
| Medtronic, Inc. | $109.43 | 1 | $0 (2023) |
| Medtronic USA, Inc. | $106.73 | 2 | $0 (2019) |
| Baxter Healthcare | $98.23 | 1 | $0 (2022) |
| Abbott Laboratories | $78.56 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,802 | 9 | Spinevision SAS ($48,608) |
| 2023 | $102,642 | 13 | Spinevision SAS ($93,173) |
| 2022 | $60,196 | 14 | Spinevision SAS ($59,904) |
| 2021 | $75.28 | 4 | Celgene Corporation ($43.56) |
| 2020 | $52,329 | 4 | Spinevision SAS ($52,287) |
| 2019 | $80,909 | 5 | Catalyst Spinal Innovations ($78,300) |
| 2018 | $225,104 | 6 | Catalyst Spinal Innovations ($214,020) |
| 2017 | $382,730 | 15 | Catalyst Spinal Innovations ($234,030) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 10/21/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $19.67 | General |
| 10/19/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $34.00 | General |
| 09/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/30/2024 | Spinevision SAS | — | Food and Beverage | Cash or cash equivalent | $210.00 | General |
| 07/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/06/2024 | Spinevision SAS | — | Royalty or License | Cash or cash equivalent | $48,398.00 | General |
| 03/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2023 | Kuros Biosciences USA, Inc | — | Food and Beverage | Cash or cash equivalent | $77.45 | General |
| 10/28/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| 10/10/2023 | Spinevision SAS | — | Consulting Fee | Cash or cash equivalent | $59,400.00 | General |
| 08/31/2023 | Medtronic, Inc. | MAGNIFUSE BONE GRAFT (Device) | Food and Beverage | In-kind items and services | $109.43 | General |
| Category: Bone Matrix/Graft | ||||||
| 08/26/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $35.46 | General |
| Category: Neurology | ||||||
| 07/23/2023 | Spinevision Inc. | — | Travel and Lodging | Cash or cash equivalent | $8,934.77 | General |
| 07/22/2023 | Spinevision Inc. | — | Food and Beverage | Cash or cash equivalent | $241.11 | General |
| 07/21/2023 | Spinevision SAS | — | Food and Beverage | Cash or cash equivalent | $105.00 | General |
| 07/11/2023 | Spinevision SAS | — | Royalty or License | Cash or cash equivalent | $33,093.00 | General |
| 05/24/2023 | Spinevision SAS | — | Travel and Lodging | Cash or cash equivalent | $575.00 | General |
| 05/23/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $18.82 | General |
| 03/08/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $18.09 | General |
| 01/26/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| 11/10/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| 10/28/2022 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Neuropsychiatry | ||||||
| 10/11/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,526 | 2,144 | $3.4M | $999,301 |
| 2022 | 22 | 1,340 | 1,996 | $3.7M | $1.1M |
| 2021 | 27 | 1,950 | 2,567 | $3.8M | $1.3M |
| 2020 | 27 | 1,664 | 2,340 | $3.9M | $1.4M |
Total Patients
6,480
Total Services
9,047
Medicare Billing
$4.8M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 22513 | Treatment of broken middle spine bone with placement of stabilizing device using imaging guidance | Office | 2023 | 54 | 60 | $939,841 | $278,724 | 29.7% |
| 22514 | Treatment of broken lower spine bone with placement of stabilizing device | Office | 2023 | 36 | 45 | $701,010 | $207,870 | 29.7% |
| 22515 | Treatment of broken spine bone with stabilizing device, each additional segment | Office | 2023 | 35 | 54 | $435,402 | $128,888 | 29.6% |
| 22633 | Fusion of spine in lower back with partial removal of spine bone and disc | Facility | 2023 | 39 | 39 | $209,196 | $63,144 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 366 | 459 | $153,306 | $44,727 | 29.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 215 | 215 | $125,053 | $36,720 | 29.4% |
| 63047 | Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | Facility | 2023 | 35 | 35 | $111,615 | $31,649 | 28.4% |
| 22214 | Incision or removal of lower spine bone segment | Facility | 2023 | 39 | 39 | $168,597 | $26,119 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 186 | 186 | $82,213 | $24,405 | 29.7% |
| 63267 | Removal of growth of lower spine bone outside spine membrane | Facility | 2023 | 19 | 19 | $76,095 | $22,962 | 30.2% |
| 22853 | Insertion of cage or mesh device to spine bone and disc space during spine fusion | Facility | 2023 | 57 | 93 | $70,122 | $21,608 | 30.8% |
| 22842 | Placement of stabilizing device to back, 3-6 spine bone segments | Facility | 2023 | 31 | 31 | $69,068 | $21,325 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 122 | 127 | $60,167 | $17,538 | 29.1% |
| 22614 | Fusion of additional segment of spine | Facility | 2023 | 24 | 36 | $41,112 | $12,697 | 30.9% |
| 22840 | Placement of stabilizing device to back of 1 spine bone in neck | Facility | 2023 | 17 | 17 | $37,604 | $11,573 | 30.8% |
| 63048 | Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | Facility | 2023 | 38 | 55 | $33,825 | $10,407 | 30.8% |
| 22845 | Placement of stabilizing device to front, 2-3 spine bone segments | Facility | 2023 | 14 | 14 | $29,848 | $9,193 | 30.8% |
| 22634 | Fusion of additional segment of spine with partial removal of spine bone and disc | Facility | 2023 | 18 | 21 | $30,471 | $9,180 | 30.1% |
| 22216 | Incision or removal of spine bone segment, each additional segment | Facility | 2023 | 26 | 26 | $27,352 | $8,418 | 30.8% |
| 61783 | Computer-assisted spinal procedure | Facility | 2023 | 32 | 32 | $22,016 | $6,788 | 30.8% |
| 69990 | Use of operating microscope | Facility | 2023 | 17 | 17 | $11,050 | $3,431 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 24 | $5,712 | $1,760 | 30.8% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 85 | 500 | $6,000 | $174.73 | 2.9% |
| 22513 | Treatment of broken middle spine bone with placement of stabilizing device using imaging guidance | Office | 2022 | 56 | 73 | $1.1M | $363,003 | 32.2% |
| 22514 | Treatment of broken lower spine bone with placement of stabilizing device | Office | 2022 | 47 | 53 | $810,507 | $260,724 | 32.2% |
About Dr. Gary Colon, MD
Dr. Gary Colon, MD is a Neurological Surgery healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821048752.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Colon, MD has received a total of $952,789 in payments from pharmaceutical and medical device companies, with $48,802 received in 2024. These payments were reported across 70 transactions from 20 companies. The most common payment nature is "" ($526,350).
As a Medicare-enrolled provider, Colon has provided services to 6,480 Medicare beneficiaries, totaling 9,047 services with total Medicare billing of $4.8M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurological Surgery
- Location Naples, FL
- Active Since 05/11/2006
- Last Updated 04/11/2024
- Taxonomy Code 207T00000X
- Entity Type Individual
- NPI Number 1821048752
Products in Payments
- ZEPOSIA (Drug) $197.76
- BOTOX (Biological) $124.44
- MAGNIFUSE BONE GRAFT (Device) $109.43
- INTELLIS (Device) $106.73
- FLOSEAL (Device) $98.23
- NVM5 (Device) $57.45
- SCS IPGs (Device) $51.90
- Leqembi (Drug) $35.46
- Ongentys (Drug) $29.64
- APTIOM (Drug) $28.50
- Algovita (Device) $26.96
- SCS leads (Device) $26.66
- NEURACEQ (Drug) $22.43
- XARELTO (Drug) $11.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurological Surgery Doctors in Naples
Dr. Mark Gerber, M.d, M.D
Neurological Surgery — Payments: $528,949
Neurological Surgery $528,949
Dr. Michael Lusk, M.d, M.D
Neurological Surgery — Payments: $524,417
Neurological Surgery $524,417
Benjamin Ditty, M.d, M.D
Neurological Surgery — Payments: $435,615
Neurological Surgery $435,615
Ahilan Sivaganesan
Neurological Surgery — Payments: $35,764
Neurological Surgery $35,764
Dr. Mark Frenkel, M.d, M.D
Neurological Surgery — Payments: $34,318
Neurological Surgery $34,318
Dr. Gennadiy Katsevman, M.d, M.D
Neurological Surgery — Payments: $18,447
Neurological Surgery $18,447